We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 6,027 results
  1. Oritavancin Versus Daptomycin for Osteomyelitis Treatment After Surgical Debridement

    Introduction

    Weekly intravenous (IV) oritavancin and daily daptomycin were compared in an outpatient setting following extensive surgical debridement...

    Nicholas W. Van Hise, Russell M. Petrak, ... Mark Redell in Infectious Diseases and Therapy
    Article Open access 29 February 2024
  2. The Combination of Daptomycin with Fosfomycin is More Effective than Daptomycin Alone in Reducing Mortality of Vancomycin-Resistant Enterococcal Bloodstream Infections: A Retrospective, Comparative Cohort Study

    Introduction

    High-dose daptomycin-based combinations are recommended for vancomycin-resistant Enterococcus (VRE) bloodstream infection (BSI)....

    Tai-Chung Tseng, Yu-Chung Chuang, ... Shan-Chwen Chang in Infectious Diseases and Therapy
    Article Open access 11 January 2023
  3. A Pharmacovigilance Analysis of Daptomycin Use Based on CLSI Susceptible Dose-Dependent Category

    Introduction

    Daptomycin doses 8–12 mg/kg are recommended for susceptible dose-dependent Enterococcus species. However, data remain limited on safety...

    Ming M. Zhang, Ryan W. Stevens, ... Christina G. Rivera in Infectious Diseases and Therapy
    Article Open access 26 September 2023
  4. The effects of daptomycin on cell wall biosynthesis in Enterococcal faecalis

    Daptomycin is a cyclic lipodepsipeptide antibiotic reserved for the treatment of serious infections by multidrug-resistant Gram-positive pathogens....

    Binayak Rimal, James Chang, ... Sung Joon Kim in Scientific Reports
    Article Open access 28 July 2023
  5. Dual release of daptomycin and BMP-2 from a composite of β-TCP ceramic and ADA gelatin

    Background

    Antibiotic-containing carrier systems are one option that offers the advantage of releasing active ingredients over a longer period of...

    Lucas Ritschl, Pia Schilling, ... Michael Seidenstuecker in BMC Biotechnology
    Article Open access 03 June 2024
  6. Usefulness of daptomycin lock therapy in children with catheter-related bacteremia after failed vancomycin lock therapy

    Purpose

    Catheter-related bacteremia (CRB) is a significant cause of morbidity, resource expenditure and prolonged hospital stays in patients with...

    Celia Permuy, Jone Ruiz-Azcárate, ... Ana Méndez-Echevarría in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 22 June 2023
  7. Population Pharmacokinetic Model for Unbound Concentrations of Daptomycin in Patients with MRSA Including Patients Undergoing Hemodialysis

    Background and Objective

    Unbound daptomycin concentrations are responsible for pharmacologically beneficial and adverse effects, although most...

    Saki Takahashi, Yasuhiro Tsuji, ... Yoshihiro Yamamoto in European Journal of Drug Metabolism and Pharmacokinetics
    Article 02 March 2023
  8. Vancomycin and daptomycin dosing recommendations in patients receiving home hemodialysis using Monte Carlo simulation

    Background

    Few drug dosing recommendations for patients receiving home hemodialysis (HHD) have been published which has hindered the adoption of HHD....

    Susan J. Lewis, Soo Min Jang, Bruce A. Mueller in BMC Nephrology
    Article Open access 14 September 2023
  9. Daptomycin

    Article 25 May 2024
  10. Daptomycin

    Article 29 June 2024
  11. Daptomycin

    Article 29 June 2024
  12. Daptomycin

    Article 29 June 2024
  13. Challenges in managing a multifactorial eosinophilic pneumonia: daptomycin vs strongyloidiasis case report

    Background

    Eosinophilia is defined as a blood eosinophil count > 500/mcL with etiology usually an allergic reaction or parasitic infection which can...

    Lynda G. J. Eckhardt, Jordan L. Kelley, Dorothy Maes in BMC Infectious Diseases
    Article Open access 22 November 2022
  14. Daptomycin

    Article 09 March 2024
  15. Daptomycin

    Article 29 June 2024
  16. Daptomycin

    Article 09 March 2024
  17. Daptomycin

    Article 29 June 2024
  18. Daptomycin

    Article 09 March 2024
  19. Population Analysis of Daptomycin-non-Susceptible Methicillin-Resistant Staphylococcus aureus Reveals the Presence of Variants That Contribute to Daptomycin Resistance

    In this study, population analysis (PA) of methicillin-resistant Staphylococcus aureus (MRSA), before and after long-duration daptomycin (DAP)...

    Izumo Kanesaka, Junya Yabuta, ... Intetsu Kobayashi in Current Microbiology
    Article 11 January 2024
  20. Daptomycin

    Article 18 November 2023
Did you find what you were looking for? Share feedback.